Dagmar Hedrich, Health and Social Responses EMCDDA expert meeting on TDI coverage, 5 February 2007 Treatment availability - ST 24 –

Slides:

Advertisements

Similar presentations

Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.

Advertisements

1.03 Healthcare Finances.

Addressing Addiction and Substance Use in National Health Reform Eric Goplerud, Ph.D. Alliance for Health Care Reform July 17, 2009 Center for Integrated.

Query Health Clinical WG Face-to-Face Meeting 10/18/2011.

TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.

Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.

European facility survey questionnaire (EFSQ) Treatment CUP.

1 TDI &Prevalence First results of pilotproject A.W.Ouwehand W.Kuijpers Lisbon: TDI meeting september 2006.

Improvement of treatment demand data quality : useful tips Sandrine Sleiman, Xavier Poos September 2006.

DMRU - Drug Misuse Research Unit Evidence for Population Health Unit School of Epidemiology & Health Sciences University of Manchester DMRU Michael Donmall.

The EMCDDA and the Reitox network: towards quality achievement Sandrine Sleiman, Scientific Committee, Palmela, February 2008.

1International Network of Drug Dependence Treatment and Rehabilitation Resource Centres Treatnet: the UNODC project Associated ASI adaptations and links.

Working Group on coverage of Treatment Demand Data Lisbon, 5 February 2007.

Status of progress of TDI indicator Notrbert Frost, Linda Montanari, EMCDDA, September 2004 Annual Expert Meeting on Treatment Demand Indicator.

N T C S at UGA * Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation Adoption of Evidence-based Practices in Addiction Treatment.

Responses to infectious diseases among people who inject drugs: Policies and measures taken in Europe Dagmar Hedrich, EMCDDA Project Imp.Ac:T - Improving.

Workshop IV: Provision of Health Care The Impact of International Standards and Guidelines on prisoner health in Eastern and Central Europe Antalya, Turkey.

Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.

SE ALARM One Day Seminar Medical Malpractice 24 th January 2007 Mike Thane AIG.

2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.

Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.

+ Opioid Substitution Therapy for Injecting Drug Users: Scale versus Quality WORKSHOP “OST in Developing Countries: A Primer” Atul Ambekar, Alok Agrawal.

Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.

Commercial (Non Government Sponsored) Health Plan Medical Cost and Premium Trends Pharmaceuticals15%14% 12% 11%1.8% Hospital Inpatient Outpatient2515.

Does Case Management Improve Linkage to Substance Abuse Treatment? By Erin.

An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.

WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,

National Research and Development Centre for Welfare and Health Knowledge for welfare and health1 Finnish Drug Treatment Information System Kristiina Kuussaari,

Jennifer Hillebrand, „Rehabilitation of Drug Addicted Persons: Experience of Lithuania and European Countries”, 18 October 2007 Improving drug treatment.

Treatment system-based data collection: an integrated approach to monitoring Expert meeting: Implementation of the treatment strategy EMCDDA Lisbon,

Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.

HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.

Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.

Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.

Should CAM be funded by the NHS? or Do you really want your tax money to be used for fashionable quackery? SIM SALA......Yin Yang Abracadabra.....

Opioid addiction treatment: Challenges (and opportunities) for community practice Marc Fishman MD.

An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.

Erik Iversen, Norway Workshop at the annual TDI expert meeting EMCDDA, Lisbon 25 September 2006 Data Coverage Assessment The Bergen Clinics Foundation,

WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,

Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.

Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.

Domains Care Model HomecareOutpatientsInpatients Primary care.

Module 1 General introduction to substitution treatment.

NDTMS – Core Dataset ‘F’ NDTMS Adult Drug & Alcohol Services Core Dataset ‘F’ February 2009 Jill Smith NEPHO – NDTMS Team.

Using the new treatment prevalence protocol in Ireland Suzi Lyons.

Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.

ÖBIG Austrian Health Institute Gender Analysis and Women in Substitution Treatment in Austria Meeting on Treatment Demand Indicator EMCDDA 23 rd September.

EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,

Medication Assisted Treatment Adding a new medication into outpatient treatment.

Data quality and feedback from the assessment on 2000 and 2001 TDI data 1 EMCDDA, TDI meeting, 23/24 June 2003 Luis Royuela.

Spectrum Health Systems Lincoln Street Opiate Treatment Program Support for this project was provided by NIATx through a grant from the National Institute.

15/03/2016Specialised psychiatric care Sami Fredriksson & Simo Pelanteri.

Modernizing Health Care Inez Bartels.  Strong focus on the provision of health care  Institutions governing health care consumption control patients.

1 Use of Pharmacotherapies by Substance Abuse Treatment Facilities November 2007 Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration.

Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.

Developing role of community pharmacy in responding to the needs of people with drug problems David Thomson Lead Pharmacist Community Pharmacy Development.

Primary health care. Outpatient physician visits in primary health care per 1000 inhabitants.

Here are 6 types of drug treatment center which can help you to get rid of drug addiction 1. Outpatient Treatment.

PSY 270 Week 1 DQ 2 There are currently several trends in the treatment of psychological disorders, including the following:  The use of psychotropic.

Drugs and Prison in Europe: State of Play

Primary health care.

Medicaid Coverage for Methadone In Illinois: AATOD Medicaid Webinar Richard Weisskopf State Opiate Treatment Authority Illinois Department of Human Services.

Cannabis epidemic or return of opoid problems or decrease of high risk drug use among young adults in Austria Addictions Lisbon 2017, Paper Session 2 –

February 12 – 19, 2018.

Freya Vander Laenen STRUCTURED SESSION Costs of drug treatment

Take-home naloxone as integral part of toolkits for public health providers: priorities across settings Dagmar Hedrich, EMCDDA Lisbon, 25 October 2017.

Linda Montanari Programme P1: Monitoring the Situation

Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV/AIDS Bach Xuan Tran, Long Thanh Nguyen

A Training For Multidisciplinary Addiction Professionals

Medically assisted treatment

Presentation transcript:

Dagmar Hedrich, Health and Social Responses EMCDDA expert meeting on TDI coverage, 5 February 2007 Treatment availability - ST 24 –

ST 24 – drug-related treatment availability Quantitative data on units, slots and clients Complementary to TDI Provision/capacity, utilisation coverage Structured acc. to approaches: medically assisted treatment /drug-free treatment Types: specialised / generic Settings: inpatient / outpatient / GP / other

Approach MATUnitsY/NSlotsClients Setting: Specialised OUT Methadone Buprenorphine Other 1 Other 2 Setting: GP Methadone Buprenorphine Other 1 Other 2 Setting: Other Methadone Buprenorphine Other 1 Other 2

Approach: drug-free UnitsSlotsClients Setting: Specialised OUT Setting: Specialised INP Setting: Generic OUT Setting: Generic INP

10-year trend in the number of substitution treatment clients in Europe (EU-15)